What is the recommended approach to treating hypertension in collegiate athletes?

Treating Hypertension in Collegiate Athletes

Collegiate athletes with stage 1 hypertension (BP 140-159/90-99 mmHg) without target-organ damage should not be restricted from any competitive sport but require BP monitoring every 2-4 months, while those with stage 2 hypertension (BP ≥160/100 mmHg) must be restricted from high-static sports until BP is controlled with lifestyle modification or pharmacotherapy using ACE inhibitors, ARBs, or calcium channel blockers as first-line agents. 1

Initial Assessment and Diagnosis

Before making treatment decisions, confirm the diagnosis properly:

• Obtain comprehensive out-of-office BP measurements for any athlete with initial readings >140/90 mmHg to exclude white-coat hypertension and measurement errors 1
• Ambulatory BP monitoring with proper cuff size is the most precise diagnostic method 1
• Perform screening echocardiography in all athletes with sustained hypertension to assess for left ventricular hypertrophy (LVH) beyond physiologic "athlete's heart" 1

Critical Pitfall: Distinguishing Physiologic from Pathologic LVH

Athletes, particularly those with larger body size and Black athletes, may have increased wall thickness on echo that represents normal adaptation rather than pathologic hypertrophy. Physiologic LVH rarely exceeds 13mm. Correlate echo findings with ECG, symptoms, and family history before restricting participation 1.

Risk Stratification and Secondary Hypertension Screening

For athletes <25 years old with stage 2 hypertension, refer to a cardiologist or hypertension specialist for evaluation of secondary causes, as this workup often exceeds the scope of primary care 1. Young athletes with hypertension warrant more aggressive secondary cause investigation 2.

Sport-specific risk factors to address:

• NSAID use
• Stimulant use (including performance-enhancing substances)
• Unhealthy dietary patterns 2

Treatment Algorithm by Hypertension Stage

Prehypertension (120-139/80-89 mmHg)

• Lifestyle modification only
• No restriction from physical activity 1

Stage 1 Hypertension (140-159/90-99 mmHg)

• No sport restriction if no target-organ damage 1
• Lifestyle modification as initial approach
• Monitor BP every 2-4 months 1
• If LVH beyond athlete's heart is present: restrict participation until BP normalized with antihypertensive therapy 1

Stage 2 Hypertension (≥160/100 mmHg)

• Restrict from high-static sports (weight lifting, boxing, wrestling) until BP controlled 1
• Initiate pharmacotherapy promptly
• May allow participation in low-static sports during treatment titration with close monitoring

Pharmacotherapy Selection

First-line agents for collegiate athletes:

1. ACE inhibitors (preferred)
2. Angiotensin receptor blockers (ARBs) (preferred)
3. Calcium channel blockers (dihydropyridine preferred)

2, 3, 4

Rationale for Drug Selection

ACE inhibitors and ARBs are preferred because they:

• Avoid salt and water losses that occur with athletic training 4
• Preserve endothelial function 4
• Do not impair exercise performance 3, 4
• Are not prohibited by NCAA or WADA 4

Calcium channel blockers (particularly dihydropyridines) are reasonable alternatives that do not impair exercise capacity 3, 4.

Agents to Avoid or Use Cautiously

Beta-blockers should NOT be first-line therapy because they:

• Impair exercise performance 4
• Are prohibited by NCAA and WADA in certain sports 4

Diuretics require caution because:

• Athletes experience substantial salt and water losses during training 4
• If used, must be registered with governing bodies and may require therapeutic exemption 1
• Can cause volume depletion and electrolyte abnormalities

Critical Compliance Consideration

When prescribing any antihypertensive, verify the drug is registered with appropriate athletic governing bodies and obtain therapeutic exemptions if necessary 1. This is particularly important for diuretics, which are often banned or restricted.

Follow-Up and Monitoring

• BP checks every 2-4 months minimum once training begins 1
• More frequent monitoring if BP control is suboptimal
• Reassess for target-organ damage if BP remains elevated
• Adjust participation restrictions based on BP control and presence of LVH

Special Considerations

Strength-trained athletes may be more susceptible to hypertension than endurance athletes, partly due to body size differences and the more potent antihypertensive effects of aerobic exercise 2. Consider this when counseling on training modifications.

When hypertension coexists with other cardiovascular disease, base eligibility decisions on the type and severity of the associated condition rather than hypertension alone 1.